147 related articles for article (PubMed ID: 16763214)
21. Activation of transglutaminase 2 by nerve growth factor in differentiating neuroblastoma cells: A role in cell survival and neurite outgrowth.
Algarni AS; Hargreaves AJ; Dickenson JM
Eur J Pharmacol; 2018 Feb; 820():113-129. PubMed ID: 29242118
[TBL] [Abstract][Full Text] [Related]
22. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination.
Van Strien ME; Baron W; Bakker EN; Bauer J; Bol JG; Brevé JJ; Binnekade R; Van Der Laarse WJ; Drukarch B; Van Dam AM
Glia; 2011 Nov; 59(11):1622-34. PubMed ID: 21818782
[TBL] [Abstract][Full Text] [Related]
23. NADPH oxidase-dependent generation of lysophosphatidylserine enhances clearance of activated and dying neutrophils via G2A.
Frasch SC; Berry KZ; Fernandez-Boyanapalli R; Jin HS; Leslie C; Henson PM; Murphy RC; Bratton DL
J Biol Chem; 2008 Nov; 283(48):33736-49. PubMed ID: 18824544
[TBL] [Abstract][Full Text] [Related]
24. Transglutaminase 2 null macrophages respond to lipopolysaccharide stimulation by elevated proinflammatory cytokine production due to an enhanced αvβ3 integrin-induced Src tyrosine kinase signaling.
Sarang Z; Köröskényi K; Pallai A; Duró E; Melino G; Griffin M; Fésüs L; Szondy Z
Immunol Lett; 2011 Jul; 138(1):71-8. PubMed ID: 21420434
[TBL] [Abstract][Full Text] [Related]
25. Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation.
Munezane T; Hasegawa T; Suritala ; Tanaka A; Okada K; Okita Y
J Vasc Surg; 2010 Oct; 52(4):967-74. PubMed ID: 20615646
[TBL] [Abstract][Full Text] [Related]
26. Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes.
Salter NW; Ande SR; Nguyen HK; Nyomba BL; Mishra S
J Mol Endocrinol; 2012 Jun; 48(3):203-16. PubMed ID: 22394545
[TBL] [Abstract][Full Text] [Related]
27. β
Vyas FS; Nelson CP; Freeman F; Boocock DJ; Hargreaves AJ; Dickenson JM
Eur J Pharmacol; 2017 Oct; 813():105-121. PubMed ID: 28754379
[TBL] [Abstract][Full Text] [Related]
28. Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy.
Johnson KA; van Etten D; Nanda N; Graham RM; Terkeltaub RA
J Biol Chem; 2003 May; 278(21):18824-32. PubMed ID: 12606540
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of transglutaminase 2 reduces efferocytosis in human macrophages: Role of CD14 and SR-AI receptors.
Eligini S; Fiorelli S; Tremoli E; Colli S
Nutr Metab Cardiovasc Dis; 2016 Oct; 26(10):922-30. PubMed ID: 27378395
[TBL] [Abstract][Full Text] [Related]
30. Some lessons from the tissue transglutaminase knockout mouse.
Sarang Z; Tóth B; Balajthy Z; Köröskényi K; Garabuczi E; Fésüs L; Szondy Z
Amino Acids; 2009 Apr; 36(4):625-31. PubMed ID: 18584284
[TBL] [Abstract][Full Text] [Related]
31. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification.
Johnson KA; Terkeltaub RA
J Biol Chem; 2005 Apr; 280(15):15004-12. PubMed ID: 15691824
[TBL] [Abstract][Full Text] [Related]
32. Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.
Carbone C; Di Gennaro E; Piro G; Milone MR; Pucci B; Caraglia M; Budillon A
Amino Acids; 2017 Mar; 49(3):517-528. PubMed ID: 27761756
[TBL] [Abstract][Full Text] [Related]
33. Extracellular transglutaminase 2 induces myotube hypertrophy through G protein-coupled receptor 56.
Kitakaze T; Yoshikawa M; Kobayashi Y; Kimura N; Goshima N; Ishikawa T; Ogata Y; Yamashita Y; Ashida H; Harada N; Yamaji R
Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118563. PubMed ID: 31666191
[TBL] [Abstract][Full Text] [Related]
34. Olfactomedin 4 contributes to hydrogen peroxide-induced NADPH oxidase activation and apoptosis in mouse neutrophils.
Liu W; Liu Y; Li H; Rodgers GP
Am J Physiol Cell Physiol; 2018 Oct; 315(4):C494-C501. PubMed ID: 29949402
[TBL] [Abstract][Full Text] [Related]
35. A cascade of Ca(2+)/calmodulin-dependent protein kinases regulates the differentiation and functional activation of murine neutrophils.
Gaines P; Lamoureux J; Marisetty A; Chi J; Berliner N
Exp Hematol; 2008 Jul; 36(7):832-44. PubMed ID: 18400360
[TBL] [Abstract][Full Text] [Related]
36. Transglutaminase type II plays a protective role in hepatic injury.
Nardacci R; Lo Iacono O; Ciccosanti F; Falasca L; Addesso M; Amendola A; Antonucci G; Craxì A; Fimia GM; Iadevaia V; Melino G; Ruco L; Tocci G; Ippolito G; Piacentini M
Am J Pathol; 2003 Apr; 162(4):1293-303. PubMed ID: 12651621
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of transglutaminase 2 accelerates the erythroid differentiation of human chronic myelogenous leukemia K562 cell line through PI3K/Akt signaling pathway.
Kang SK; Lee JY; Chung TW; Kim CH
FEBS Lett; 2004 Nov; 577(3):361-6. PubMed ID: 15556610
[TBL] [Abstract][Full Text] [Related]
38. Lack of transglutaminase 2 diminished T-cell responses in mice.
Kim JH; Hong JM; Jeong EM; Lee WJ; Kim HR; Kang JS; Kim IG; Hwang YI
Immunology; 2014 Jul; 142(3):506-16. PubMed ID: 24628083
[TBL] [Abstract][Full Text] [Related]
39. Tissue Transglutaminase contributes to myelin phagocytosis in interleukin-4-treated human monocyte-derived macrophages.
Sestito C; Brevé JJP; Bol JGJM; Wilhelmus MMM; Drukarch B; van Dam AM
Cytokine; 2020 Apr; 128():155024. PubMed ID: 32032932
[TBL] [Abstract][Full Text] [Related]
40. Transglutaminase 2: an enigmatic enzyme with diverse functions.
Fesus L; Piacentini M
Trends Biochem Sci; 2002 Oct; 27(10):534-9. PubMed ID: 12368090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]